Shire Pharmaceuticals Group plc (SHPGY) Published Study Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Provided Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
8/5/2010 10:34:50 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Initiates Two Adult ADHD Outreach Programs
8/17/2009 8:32:47 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY)'s New Gaucher Drug Moves Closer to Market Following Positive Phase III Trial Results
8/3/2009 6:38:31 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
7/16/2009 6:54:40 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Closing Owings Mills Plant to Focus on New Drug Deals; Company to Layoff 260 Workers Over Next Three Years
4/3/2009 4:17:32 PM
More...
|
Two Lots of Noven Pharmaceuticals Inc. (NOVN), Shire Pharmaceuticals Group plc (SHPGY) ADHD Patch Recalled
8/25/2008 7:26:19 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) to Create 680 Jobs in Massachusetts, Momentive Performance Materials to Create 150 Jobs in New York
8/19/2008 7:39:03 AM
More...
|
Jerini AG Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE
7/15/2008 7:27:27 AM
More...
|
Noven Pharmaceuticals Inc. (NOVN) Provides Update on Daytrana(TM) Methylphenidate Transdermal System; Shire Pharmaceuticals Group plc (SHPGY) Undertakes Voluntary Recall of Two Lots
6/9/2008 7:15:21 AM
More...
|
Application for Listing of Shire Pharmaceuticals Group plc (SHPGY) Limited Ordinary Shares
5/23/2008 10:31:15 AM
More...
|
|